iNOS-mediated nitric oxide production and its regulation

Aktan F.

LIFE SCIENCES, cilt.75, sa.6, ss.639-653, 2004 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 75 Sayı: 6
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1016/j.lfs.2003.10.042
  • Dergi Adı: LIFE SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.639-653
  • Anahtar Kelimeler: nitric oxide, iNOS, inflammation, NFkB, LPS, NF-KAPPA-B, SMOOTH-MUSCLE-CELLS, SYNTHASE MESSENGER-RNA, PANCREATIC BETA-CELLS, HYDROXY-L-ARGININE, NO SYNTHASE, TRANSFORMING GROWTH-FACTOR-BETA-1, MITOCHONDRIAL RESPIRATION, MOUSE MACROPHAGES, OXIDATIVE STRESS
  • Ankara Üniversitesi Adresli: Evet

Özet

This review focuses on the production of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) and its regulation under physiological and pathophysiological conditions. NO is an imporant biological mediator in the living organism that is synthesized from L-arginine using NADPH and molecular oxygen. However, the overproduction of NO which is catalyzed by iNOS, a soluble enzyme and active in its dimeric form, is cytotoxic. Immunostimulating cytokines or bacterial pathogens activate iNOS and generate high concentrations of NO through the activation of inducible nuclear factors, including NFkB. iNOS activation is regulated mainly at the transcriptional level, but also at posttranscriptional, translational and postranslational levels through effects on protein stability, dimerization, phosphorylation, cofactor binding and availability of oxygen and L-arginine as subsrates. The prevention of the overproducion of NO in the living organism through control of regulatory pathways may assist in the treatment of high NO-mediated disorders without changing physiological levels of NO. (C) 2004 Elsevier Inc. All rights reserved.